Medicinal Leech Therapy in Acute Herpes Zoster Condition- A Case Report

Herpes zoster is an acute viral skin disease characterized by the painful skin rashes, burning sensation, blisters, and post-herpetic neuralgia caused by varicella zoster virus (VZV). In immune-compromised people, many dermatomes are implicated. In Ayurveda, it is correlated with visarpa having the same clinical presentation as herpes zoster. The study aims to explore the effectiveness of medicinal leech therapy and internal ayurvedic medicinal formulation in acute herpes zoster conditions. A 26-year-old male patient visited OPD (outpatient department) with a complaint of reddish rashes and a small vesicular eruption over the left lateral aspect of the chest associated with a burning sensation and pain. Leech therapy was performed promptly as an emergency treatment, along with internal medication for the next 10 days. This case report concludes that Leech therapy and internal ayurvedic medicine are found to be effective management of acute herpes zoster.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Peer-reviewed research on therapeutic compound development relevant to leech-derived anticoagulants and antithrombotic agents. Indexed in PubMed and verified against the NCBI record.

Explore how this research connects to clinical practice

More peer-reviewed studies in Drug Development.

• Hirudotherapy in Medicine and Dentistry — Jha K et al. (2015)
• Leech therapy: a history — Hyson J (2005)
• Hirudins of the Asian medicinal leech, Hirudinaria manillensis: same same, but different — Lukas P et al. (2019)
• Transcriptomic analysis of the salivary gland of medicinal leech Hirudo nipponia — Lu Z et al. (2018)
• Molecular dynamic and pharmacological studies on protein-engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis — Sun Y et al. (2022)
• Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis — Wüstenhagen D et al. (2020)
• Hirudin variants production by genetic engineered microbial factory — Zhang J, Lan N (2018)
• Hirudin in heparin-induced thrombocytopenia — Lubenow N, Greinacher A (2002)
• Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis — Han J et al. (2023)
• Hirudin as alternative anticoagulant--a historical review — Markwardt F (2002)

Browse all ASH-analysed research →